Studies Highlight Results of PiXL Procedure for Non-Invasive Treatment of Low Myopia
Avedro said that non-surgical photorefractive intrastromal corneal collagen cross-linking, or PiXL, is a promising new treatment for vision improvement for low myopia, according to the results of two studies announced at the XXXIV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS).
"PiXL is a groundbreaking, first-in-category development in the field of vision improvement," said Rajesh K. Rajpal, MD, Chief Medical Officer, Avedro. "We are thrilled with the progress in our clinical development and believe that PiXL represents a new non-invasive treatment paradigm for patients with low myopia. We are pleased to see these very promising early results."
According to a release, the first study, a prospective clinical trial conducted at Ruhr University Eye Hospital, Bochum, Germany, evaluated the safety and efficacy of epithelium-off PiXL. This 12 month study included 39 eyes (phakic and pseudophakic) in 2 groups (group 1: MRSE -1.0 D to -2.0 D, cyl. max. -0.75 D; group 2: MRSE -2.0 D to -3.0 D, cyl. max. -0.75 D).
Preliminary results at 12 months demonstrate significant improvement with mean uncorrected visual acutiy (UCVA) of 20/20 at 12 months, and no loss of best-corrected visual acuity (BCVA). Based on these early results, the data demonstrate that PiXL is a promising refractive procedure for low myopia, offering the potential for vision improvement without tissue ablation.
"The preliminary 12 month results build upon what we observed at the three and six month evaluations," said Dr. Matthias Elling, FEBO, Ruhr University Eye Hospital, Bochum, Germany. "Based on these outcomes, the long-term stability of PiXL treatment appears favorable. It is exciting to see the potential of this new procedure for the large numbers of patients currently wearing contact lenses who have chosen not to have traditional refractive surgery."
The second study, performed at Eagle Eye Centre in Singapore, designed to analyze the safety and efficacy of trans-epithelial PiXL in correcting low myopia, evaluated treatment results in 8 patients (14 myopic eyes, -1.62 0.6D, range -0.75 to -2.625D) who underwent the procedure and were followed for 9 months postoperatively. Efficacy findings included a mean myopia reduction of 0.75D at 9 months. Safety evaulations found no significant loss in endothelial cell count or BCVA, and no significant corneal haze post-procedure. A questionnaire administered at 6 months post-op also found high levels of patient satisfaction.
"In addition to the positive safety and efficacy findings, we were pleased to find a high satisfaction rate for the procedure with patients," said Dr. Lim Wee Kiak of Eagle Eye Centre in Singapore. "Current refractive procedures are invasive and weaken the cornea. PiXL is revolutionary in that it improves the refractive error by stiffening the cornea, while also being non-invasive. This technology has huge potential as an addition to our armamentarium for refractive corrections."
((Comments on this story may be sent to firstname.lastname@example.org))
THE DAILY VIEW
Tea Forté Introduces ‘Matcha’ Collection
Convenience meets tradition in Tea Forté’s new Ceremonial Matcha Bowl Set and the Matcha Single Steeps.
The company said its spring harvested, shade grown, stone ground, organic matcha tea is best served in a centuries-old Japanese tea ceremony called chanoyu: a preparation technique known for its centering meditative qualities.
"The launch of Tea Forté's Matcha collection represents our continued commitment to wellness and cultivating all the potential mental and physical health benefits of tea," says Tea Forté CEO Michael Gebrael. "In addition to our high quality Pure Matcha, we've also blended four distinct flavored Matcha varieties. Prepackaged in pouches measured out for a single serving, our Single Steeps Matcha is ideal for the office, travel, or to keep with you for a boost anytime."
Tea Forté noted its handcrafted ceremonial tea bowl, handmade bamboo whisk and measuring ladle “encourages serene enjoyment of our premium Kosher, gluten-free and vegan matcha blends.” These include: Pure Matcha, Chocolate Matcha, Coconut Matcha, Ginger Matcha, and Chai Matcha.
According to a release, in addition to its distinctive taste, matcha is prized for its health benefits. Steeped green tea contains only the antioxidants that can be extracted in water, while with matcha, the whole leaf is consumed.
Available now in select stores and online at teaforte.com.
Expedia.com has released a year-end look at U.S. traveler behavior and trends for 2017, analyzing data to identify the most in-demand destinations, hotels, activities and more.
Among other insights, the roundup revealed:
- Labor Day was the busiest weekend for car rental
- Disney Theme Parks topped the list of things to do
- The average hotel stay was two nights
- Top destinations based on 2017 air travel included major global cities like New York, London and Bangkok
- Popular tourist destinations included Orlando, Cancun and Las Vegas